Cambridge Investment Research Advisors Inc. Has $9.37 Million Position in Cigna Group (NYSE:CI)

Cambridge Investment Research Advisors Inc. lessened its position in Cigna Group (NYSE:CI - Free Report) by 4.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 28,472 shares of the health services provider's stock after selling 1,391 shares during the period. Cambridge Investment Research Advisors Inc.'s holdings in Cigna Group were worth $9,367,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of CI. TCTC Holdings LLC acquired a new position in Cigna Group during the fourth quarter worth $25,000. Putney Financial Group LLC acquired a new stake in Cigna Group in the fourth quarter valued at $36,000. Transce3nd LLC acquired a new stake in Cigna Group in the fourth quarter valued at $38,000. Ameriflex Group Inc. acquired a new stake in Cigna Group in the fourth quarter valued at $44,000. Finally, Heck Capital Advisors LLC acquired a new stake in Cigna Group in the fourth quarter valued at $53,000. Institutional investors own 86.99% of the company's stock.

Cigna Group Stock Performance

NYSE:CI traded down $3.32 during mid-day trading on Friday, reaching $326.68. 3,402,333 shares of the company's stock were exchanged, compared to its average volume of 1,720,207. Cigna Group has a one year low of $262.03 and a one year high of $370.83. The firm has a market capitalization of $87.27 billion, a PE ratio of 18.09, a price-to-earnings-growth ratio of 0.97 and a beta of 0.44. The business's fifty day simple moving average is $320.64 and its two-hundred day simple moving average is $308.08. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.72 and a current ratio of 0.72.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping analysts' consensus estimates of $6.35 by $0.39. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. The business had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. During the same period last year, the firm earned $6.47 earnings per share. Cigna Group's revenue for the quarter was up 14.4% compared to the same quarter last year. Analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd were issued a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 1.85%. The ex-dividend date was Tuesday, June 3rd. Cigna Group's dividend payout ratio is currently 33.44%.

Wall Street Analyst Weigh In

A number of brokerages have commented on CI. Royal Bank Of Canada reiterated an "outperform" rating and issued a $371.00 price target on shares of Cigna Group in a research note on Thursday. Cowen reiterated a "buy" rating on shares of Cigna Group in a research note on Monday, May 5th. Cantor Fitzgerald increased their price target on shares of Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a research note on Thursday, March 20th. Wall Street Zen upgraded shares of Cigna Group from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, April 8th. Finally, TD Cowen upgraded shares of Cigna Group to a "strong-buy" rating in a research note on Monday, June 23rd. Two equities research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Cigna Group currently has an average rating of "Buy" and a consensus price target of $380.39.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.